Dan G. Duda

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Papers

Driven by 60 papers — median percentile 0. Top paper: “Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma”.

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2500

N/A

0.835DataRank · unranked

261 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients

Proceedings of the National Academy of Sciences(2015)10.1073/pnas.1518808112

N/A

0.833DataRank · unranked

257 citations

Yves Boucher, Dan G. Duda, John D. Martin, Giorgio Seano, Marek Ancukiewicz +13 more

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001435

N/A

0.754DataRank · unranked

151 citations

Aya Matsui, Hiroto Kikuchi, Sebastian Klein, Émilie Mamessier, Ivy X. Chen +21 more

Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-1630

N/A

0.596DataRank · unranked

52 citations

Jessica M. Posada, Sonu Subudhi, Ashwin S. Kumar, Spencer R. Rosario, Liqun Gu +13 more

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget(2022)10.18632/oncotarget.28322

N/A

0.434DataRank · unranked

17 citations

Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao +13 more

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-6

N/A

0.330DataRank · unranked

8 citations

Betül Gök Yavuz, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu +13 more

Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab

medRxiv(2024)10.1101/2024.10.08.24315092

N/A

0.208DataRank · unranked

3 citations

Milan Parikh, Leon Pappas, Moshe Sade-Feldman, Anupriya S. Kulkarni, Lynn Bi +19 more

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Future Oncology(2025)10.1080/14796694.2025.2485020

N/A

0.176DataRank · unranked

2 citations

Sarah Colby, Paul E. Oberstein, Dan G. Duda, Robin Park, Rajiv Agarwal +12 more

Liver fibrosis uncouples tumor control from survival after multikinase inhibitor immunotherapy in hepatocellular carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.20.563378

N/A

0.165DataRank · unranked

2 citations

Hiroto Kikuchi, Atsuyo Morita, Tatsuya Kobayashi, Grace Birch, Zhiping Ruan +14 more

Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.26.525680

N/A

0.165DataRank · unranked

2 citations

Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Zelong Liu, Sarah M. Shin +17 more

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

medRxiv(2024)10.1101/2024.03.14.24304306

N/A

0.165DataRank · unranked

2 citations

Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D. Butner, Carmine Schiavone +9 more

Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

Oncotarget(2021)10.18632/oncotarget.27924

N/A

0DataRank · unranked

3 citations

Sunyoung Lee, Lianchun Xiao, Manal M. Hassan, Aliya Qayyum, Rikita Hiatia +12 more

Combining p53 mRNA nanotherapy with immune checkpoint blockade reprograms the immune microenvironment for effective cancer therapy

Nature Communications(2022)10.1038/s41467-022-28279-8

N/A

0DataRank · unranked

261 citations

Jiang Chen, Hui Zhou, Xiaodong Zeng, Zhiping Ruan, Zhangya Pu +9 more

Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac051

N/A

0DataRank · unranked

73 citations

Aya Matsui, Satoru Morita, Zohreh Amoozgar, Koetsu Inoue, Zhiping Ruan +7 more

A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1169

N/A

0DataRank · unranked

32 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more

Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0486

N/A

0DataRank · unranked

15 citations

Ryan M. Lanning, Vikash P. Chauhan, Margaret R. Martin, Ahmed S. Mousa, Walid S. Kamoun +10 more

Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis

Scientific Reports(2022)10.1038/s41598-022-15948-3

N/A

0DataRank · unranked

14 citations

Crystal Dupuis, Malea Williams, K. Dixon, Amanda McWatters, Jie Zhang +6 more

Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers

International Journal of Molecular Sciences(2022)10.3390/ijms23041926

N/A

0DataRank · unranked

4 citations

Hannah Roberts, Theodore S. Hong, Dan G. Duda, Franziska Hauth

Refining genetic and molecular classifications to facilitate breakthrough treatments in intrahepatic cholangiocarcinoma: are we there yet?

Gut(2022)10.1136/gutjnl-2022-327782

N/A

0DataRank · unranked

1 citations

Dan G. Duda, Satoru Morita

Characterization of Morreton Virus (MORV) as a Novel Oncolytic Virotherapy Platform for Liver Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.10.483848

N/A

0DataRank · unranked

3 citations

Yumei Zhou, Emilien Loeuillard, Chelsae Dumbauld, Oumar Barro, Natalie Elliott +22 more

Inflammasome targeting with an NLRP3 agonist therapy is feasible but ineffective in murine hepatocellular carcinoma models with liver damage

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.23.497362

N/A

0DataRank · unranked

0 citations

Zelong Liu, Chen Jiang, Koetsu Inoue, Zhiping Ruan, Lingling Zhu +5 more

IFNA pathway drives the more aggressive phenotype of KRAS G12D -mutant pancreatic ductal adenocarcinomas via IFNAR1/STAT3 activation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.29.497540

N/A

0DataRank · unranked

0 citations

Daniel H. Schanne, Aya Matsui, Pin‐Ji Lei, Sebastian Klein, Shuichi Aoki +20 more

A Chemoimmunotherapy Nanogel Enables Efficient Delivery of Interleukin‐2 and Induction of Immunogenic Cell Death for Effective Cancer Therapy

Advanced Functional Materials(2023)10.1002/adfm.202303033

N/A

0DataRank · unranked

18 citations

Yen‐Nhi Ngoc Ta, Max Jing Rui Tham, Fu‐Fei Hsu, Yu‐Chieh Lin, Hsi‐Chien Huang +14 more

Predicting Severity of Radiation Induced Lymphopenia in Individual Proton Therapy Patients for Varying Dose Rate and Fractionation Using Dynamic 4-Dimensional Blood Flow Simulations

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.01.054

N/A

0DataRank · unranked

26 citations

Jungwook Shin, Stella Xing, Chris Beekman, Jan Schuemann, Theodore S. Hong +10 more

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

npj Precision Oncology(2023)10.1038/s41698-023-00358-z

N/A

0DataRank · unranked

25 citations

Elke Firat, Sonja Adebahr, Erika Graf, Ilinca Popp, Gianluca Radicioni +7 more

Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients

Gastric Cancer(2023)10.1007/s10120-023-01429-7

N/A

0DataRank · unranked

24 citations

Vlad Herlea, Simona Dima, Andrei Sorop, Catalin Pechianu, Alexandru Procop +10 more

A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment

Research Square(2023)10.21203/rs.3.rs-3089359/v1

N/A

0DataRank · unranked

2 citations

Simona Dima, Andrei Sorop, Shuji Kitahara, Namrata Setia, Mihaela Chivu‐Economescu +10 more

In vivo quantification of programmed death-ligand-1 expression heterogeneity in tumors using fluorescence lifetime imaging

Research Square(2023)10.21203/rs.3.rs-3222037/v1

N/A

0DataRank · unranked

1 citations

Rahul Pal, Murali Krishnamoorthy, Aya Matsui, Homan Kang, Satoru Morita +6 more

A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment

Research Square(2023)10.21203/rs.3.rs-3547043/v1

N/A

0DataRank · unranked

1 citations

Eleni Gkika, Elke Firat, Sonja Adebahr, Erika Graf, Alexandra Eichhorst +8 more

Data from Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation

(2023)10.1158/0008-5472.c.6500525

N/A

0DataRank · unranked

0 citations

Walid S. Kamoun, Yuhui Huang, Michelle Dawson, Rakesh K. Jain, Dan G. Duda +1 more

Data from Exploratory Analysis of Early Toxicity of Sunitinib in Advanced Hepatocellular Carcinoma Patients: Kinetics and Potential Biomarker Value

(2023)10.1158/1078-0432.c.6518151

N/A

0DataRank · unranked

0 citations

Dan G. Duda, Marek Ancukiewicz, Emmanuelle di Tomaso, Jeffrey W. Clark, Rebecca A. Miksad +4 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Data from A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

(2023)10.1158/1078-0432.c.6532608.v1

N/A

0DataRank · unranked

0 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more

Data from Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition

(2023)10.1158/1078-0432.c.6532584.v1

N/A

0DataRank · unranked

0 citations

Ryan M. Lanning, Vikash P. Chauhan, Margaret R. Martin, Sahar M. Mousa, Walid S. Kamoun +10 more

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

(2023)10.1158/1078-0432.c.6530168.v1

Top 100%

0DataRank

Top 100%0 citations

Annette M. Molinaro, Katherine B. Peters, Jennifer Clarke, Justin T. Jordan, John de Groot +17 more

Cancer tissue of origin constrains the growth and metabolism of metastases

Nature Metabolism(2024)10.1038/s42255-024-01105-9

N/A

0DataRank · unranked

34 citations

Yetiş Gültekin, Peter Winter, Sidney Y. Vermeulen, Konstantine Tchourine, Keene L. Abbott +22 more

Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-0486

N/A

0DataRank · unranked

28 citations

Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Zelong Liu, Sarah M. Shin +20 more

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

Molecular Cancer(2024)10.1186/s12943-024-02060-5

N/A

0DataRank · unranked

24 citations

Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D. Butner, Carmine Schiavone +9 more

Combination CXCR4 and PD-1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma

Cancer Immunology Research(2024)10.1158/2326-6066.cir-24-0324

N/A

0DataRank · unranked

21 citations

Pin‐Ji Lei, Kohei Shigeta, Tomofumi Ando, Tatsuya Kobayashi, Hiroto Kikuchi +5 more

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110091

N/A

0DataRank · unranked

9 citations

Sergey V. Kozin, Aya Matsui, Saveli Goldberg, Shuichi Aoki, Kohei Shigeta +6 more

Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

Cancer Biomarkers(2024)10.3233/cbm-230431

N/A

0DataRank · unranked

12 citations

Sunyoung S. Lee, Tarık Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao +17 more

Fluorescence Lifetime Imaging Enables In Vivo Quantification of PD-L1 Expression and Intertumoral Heterogeneity

Cancer Research(2024)10.1158/0008-5472.can-24-0880

N/A

0DataRank · unranked

10 citations

Murali Krishnamoorthy, Aya Matsui, Homan Kang, Satoru Morita, Hajime Taniguchi +6 more

A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy

ACS Pharmacology & Translational Science(2024)10.1021/acsptsci.4c00358

N/A

0DataRank · unranked

5 citations

Subhasish Tapadar, Zhiping Ruan, Carrie Sun, Rebecca S. Arnold, Alexis Johnston +8 more

Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200913

N/A

0DataRank · unranked

5 citations

Yuguo Zhang, Khandoker Usran Ferdous, Mika Taylor, Aleksandra Cios, Randal S. Shelton +26 more

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma(2024)10.2147/jhc.s452564

N/A

0DataRank · unranked

2 citations

Michael LaPelusa, Lianchun Xiao, Yehia I. Mohamed, Sunyoung Lee, Zishuo Hu +8 more

A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.27.587062

N/A

0DataRank · unranked

1 citations

Subhasish Tapadar, Zhiping Ruan, Carrie Sun, Rebecca S. Arnold, Alexis Johnston +8 more

Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma

Nature Communications(2025)10.1038/s41467-025-66581-3

N/A

0DataRank · unranked

2 citations

Zelong Liu, Chengzhan Zhu, Tatsuya Kobayashi, Pin‐Ji Lei, Yue Shi +14 more

A tumor microenvironment-based classification of gastric cancer for more effective diagnosis and treatment

Surgical Oncology(2025)10.1016/j.suronc.2025.102298

N/A

0DataRank · unranked

1 citations

Andrei Sorop, Shuji Kitahara, Namrata Setia, Mihaela Chivu‐Economescu, Lilia Matei +10 more

A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatment

Radiotherapy and Oncology(2025)10.1016/j.radonc.2025.110889

N/A

0DataRank · unranked

2 citations

Elke Firat, Sonja Adebahr, Erika Graf, Ilinca Popp, Alexandra Eichhorst +9 more

Data from A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

(2023)10.1158/1078-0432.c.6532608

N/A

0DataRank · unranked

0 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more

Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development

UNC Libraries(2020)10.17615/02e0-mp93

N/A

0DataRank · unranked

1 citations

Ling-Hsuan Chen, Anthony Y. Wu, Dongyu Gao, Tsaiyu Chiang, Chih-Chun Chang +12 more

IGF-Child-Turcotte-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16660

N/A

0DataRank · unranked

1 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +9 more

IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.488

N/A

0DataRank · unranked

0 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +8 more

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation

UNC Libraries(2020)10.17615/bqkd-tp85

N/A

0DataRank · unranked

0 citations

Kamila Naxerova, Carlos L. Arteaga, Xiaolong Qi, Dai Fukumura, Ram C. Shankaraiah +28 more

Fatty acid synthesis is required for breast cancer brain metastasis

Nature Cancer(2021)10.1038/s43018-021-00183-y

N/A

0DataRank · unranked

325 citations

Ahmed Ali, Alba Luengo, David P. Kodack, Amy Deik, Keene L. Abbott +31 more

Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2105323118

N/A

0DataRank · unranked

90 citations

Igor L. Gomes‐Santos, Shuichi Aoki, Meenal Datta, Kosuke Kawaguchi, Nilesh P. Talele +19 more

Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma

Gut(2021)10.1136/gutjnl-2020-322493

N/A

0DataRank · unranked

81 citations

Koetsu Inoue, Sebastian Klein, Stefan Halvorsen, Jiang Chen, Aya Matsui +28 more

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients

npj Precision Oncology(2021)10.1038/s41698-021-00197-w

N/A

0DataRank · unranked

44 citations

Ashwin S. Kumar, Jessica M. Posada, Evisa Gjini, Kathleen L. Pfaff, Mikel Lipschitz +6 more

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study

npj Breast Cancer(2021)10.1038/s41523-021-00287-9

N/A

0DataRank · unranked

51 citations

Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo Pastorello +11 more

Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model

Radiation Oncology(2021)10.1186/s13014-021-01775-9

N/A

0DataRank · unranked

27 citations

Sen Li, Ivy X. Chen, Yujiao Liu, Rakesh R. Ramjiawan, Chi‐Ho Leung +7 more

Dan G. Duda

Indexed papers

Top data-sharing exemplar

Papers